Aspen Biosciences
banner
aspenbio.bsky.social
Aspen Biosciences
@aspenbio.bsky.social
22 followers 83 following 12 posts
Posts Media Videos Starter Packs
Reposted by Aspen Biosciences
We're excited to present LeaVS, a method to scale up learning for protein function models. It is based on the co-design of wet lab experiments and in silico training.
Reposted by Aspen Biosciences
Despite all of the uncertainty in the industry, those two elements continue to be a high priority for investors. They want to know how you're going to get the rest of your pipeline across the finish the line in the most capital efficient manner possible.
The past couple of years have been challenging for biotech companies. At #JPM2025, investors were looking for two things: Phase II results, and a #DigitalTransformation story that showed how #AI, #automation and advanced analytics would be used to advance early stage programs into the clinic.
Reposted by Aspen Biosciences
for 10 years I have been giving an introduction into protein structure at the Zuyd applied university (two short lectures, two short practicals).

We have been using Proteopedia, because it is Open, it is free, it is interactive, and is powered by Jmol […]

[Original post on social.edu.nl]
This is the new reality of drug discovery. What are your six impossible things?
For scientists, it’s :

- Planning new discovery programs

- Coordinating work with scientists across multiple labs and CROs

- Running synthesis requests and assays

- Generating, collecting, and analyzing all the data

...and then doing it all over again.
The pandemic taught us we can do six impossible things before breakfast —like getting new medicines to patients faster by collaborating across time zones 24/7.

Now, that "impossible" pace is the daily routine.

#DrugDiscovery #Biotech #Science #Rnd #Pharma #Innovation
6 Impossible Things
YouTube video by Aspen Biosciences
youtu.be
Watch the video on our YouTube channel for a brief preview.
youtu.be/6fPV1bIttnA?...
youtu.be
Our latest whitepaper contains case studies, examples and implementation strategies that you can apply to improve your drug discovery operations. aspenbiosciences.com/whitepapers/...
In our series "Across The Great Divide" we're taking a look at the "Great Divide" between drug discovery and drug development projects and how drug discovery project planning can improve the capital efficiency of your programs and the…

https://aspenbiosciences.com/across-the-great-divide-part-2/
Reposted by Aspen Biosciences
Reposted by Aspen Biosciences
The full panel discussion from our “Era of TechBio” event at #JPM25 is online! Hear from leading voices at the intersection of investment, technology & healthcare discussing the latest wins & remaining obstacles & how breakthroughs like LLMs & AI agents are allowing us to scale. youtu.be/GM9l8Pi8CYs
Recursion's "Era of TechBio" Panel at JPM Featuring Dean Li, Kimberly Powell, Alex Gorsky & Tony Kim
YouTube video by Recursion
youtu.be